Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

LNTH vs RMD vs MDT vs PHG

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
LNTH
Lantheus Holdings, Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • US
Market Cap$5.92B
5Y Perf.+562.8%
RMD
ResMed Inc.

Medical - Instruments & Supplies

HealthcareNYSE • US
Market Cap$30.15B
5Y Perf.+28.7%
MDT
Medtronic plc

Medical - Devices

HealthcareNYSE • IE
Market Cap$99.94B
5Y Perf.-20.9%
PHG
Koninklijke Philips N.V.

Medical - Devices

HealthcareNYSE • NL
Market Cap$25.84B
5Y Perf.-34.1%

LNTH vs RMD vs MDT vs PHG — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
LNTH logoLNTH
RMD logoRMD
MDT logoMDT
PHG logoPHG
IndustryDrug Manufacturers - Specialty & GenericMedical - Instruments & SuppliesMedical - DevicesMedical - Devices
Market Cap$5.92B$30.15B$99.94B$25.84B
Revenue (TTM)$1.55B$5.54B$35.48B$17.83B
Net Income (TTM)$279M$1.52B$4.61B$895M
Gross Margin60.5%61.7%61.9%45.2%
Operating Margin18.8%34.3%17.9%8.0%
Forward P/E17.5x18.8x14.1x17.5x
Total Debt$738K$852M$28.52B$8.09B
Cash & Equiv.$359M$1.21B$2.22B$2.79B

LNTH vs RMD vs MDT vs PHGLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

LNTH
RMD
MDT
PHG
StockMay 20May 26Return
Lantheus Holdings, … (LNTH)100662.8+562.8%
ResMed Inc. (RMD)100128.7+28.7%
Medtronic plc (MDT)10079.1-20.9%
Koninklijke Philips… (PHG)10065.9-34.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: LNTH vs RMD vs MDT vs PHG

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: RMD and MDT are tied at the top with 3 categories each — the right choice depends on your priorities. Medtronic plc is the stronger pick specifically for capital preservation and lower volatility and dividend income and shareholder returns. PHG also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
LNTH
Lantheus Holdings, Inc.
The Long-Run Compounder

LNTH is the clearest fit if your priority is long-term compounding and sleep-well-at-night.

  • 41.9% 10Y total return vs RMD's 293.8%
  • Lower volatility, beta 0.47, Low D/E 0.1%, current ratio 2.70x
Best for: long-term compounding and sleep-well-at-night
RMD
ResMed Inc.
The Growth Play

RMD carries the broadest edge in this set and is the clearest fit for growth exposure and valuation efficiency.

  • Rev growth 9.8%, EPS growth 37.4%, 3Y rev CAGR 12.9%
  • PEG 1.08 vs MDT's 36.00
  • 9.8% revenue growth vs PHG's -1.0%
  • Better valuation composite
Best for: growth exposure and valuation efficiency
MDT
Medtronic plc
The Income Pick

MDT is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.

  • Dividend streak 36 yrs, beta 0.47, yield 3.6%
  • Beta 0.47, yield 3.6%, current ratio 1.85x
  • Beta 0.47 vs PHG's 1.12, lower leverage
  • 3.6% yield, 36-year raise streak, vs PHG's 1.5%, (1 stock pays no dividend)
Best for: income & stability and defensive
PHG
Koninklijke Philips N.V.
The Momentum Pick

PHG is the clearest fit if your priority is momentum.

  • +17.7% vs RMD's -14.5%
Best for: momentum
See the full category breakdown
CategoryWinnerWhy
GrowthRMD logoRMD9.8% revenue growth vs PHG's -1.0%
ValueRMD logoRMDBetter valuation composite
Quality / MarginsRMD logoRMD27.4% margin vs PHG's 5.0%
Stability / SafetyMDT logoMDTBeta 0.47 vs PHG's 1.12, lower leverage
DividendsMDT logoMDT3.6% yield, 36-year raise streak, vs PHG's 1.5%, (1 stock pays no dividend)
Momentum (1Y)PHG logoPHG+17.7% vs RMD's -14.5%
Efficiency (ROA)MDT logoMDT175.8% ROA vs PHG's 3.4%, ROIC 6.0% vs 6.4%

LNTH vs RMD vs MDT vs PHG — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

LNTHLantheus Holdings, Inc.
FY 2025
Product
33.4%$1.5B
Radiopharmaceutical Oncology
21.9%$989M
PYLARIFY
21.9%$989M
Total Precision Diagnostics
10.9%$493M
DEFINITY
7.3%$330M
Techne Lite
1.9%$87M
Strategic Partnerships And Other
1.3%$59M
Other (2)
1.3%$59M
RMDResMed Inc.
FY 2024
Sleep And Respiratory
87.5%$4.1B
Software As Service
12.5%$584M
MDTMedtronic plc
FY 2025
Cardiac and Vascular Group
37.3%$12.5B
Neuroscience Group
29.4%$9.8B
Medical Surgical
25.1%$8.4B
Diabetes Group
8.2%$2.8B
PHGKoninklijke Philips N.V.

Segment breakdown not available.

LNTH vs RMD vs MDT vs PHG — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLRMDLAGGINGLNTH

Income & Cash Flow (Last 12 Months)

RMD leads this category, winning 4 of 6 comparable metrics.

MDT is the larger business by revenue, generating $35.5B annually — 22.9x LNTH's $1.5B. RMD is the more profitable business, keeping 27.4% of every revenue dollar as net income compared to PHG's 5.0%. On growth, RMD holds the edge at +10.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricLNTH logoLNTHLantheus Holdings…RMD logoRMDResMed Inc.MDT logoMDTMedtronic plcPHG logoPHGKoninklijke Phili…
RevenueTrailing 12 months$1.5B$5.5B$35.5B$17.8B
EBITDAEarnings before interest/tax$347M$2.1B$9.4B$2.5B
Net IncomeAfter-tax profit$279M$1.5B$4.6B$895M
Free Cash FlowCash after capex$372M$1.8B$5.4B$755M
Gross MarginGross profit ÷ Revenue+60.5%+61.7%+61.9%+45.2%
Operating MarginEBIT ÷ Revenue+18.8%+34.3%+17.9%+8.0%
Net MarginNet income ÷ Revenue+18.0%+27.4%+13.0%+5.0%
FCF MarginFCF ÷ Revenue+24.0%+31.7%+15.2%+4.2%
Rev. Growth (YoY)Latest quarter vs prior year+1.2%+10.8%+8.8%+1.1%
EPS Growth (YoY)Latest quarter vs prior year+76.5%+9.3%-11.9%+2.1%
RMD leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

PHG leads this category, winning 3 of 7 comparable metrics.

At 21.6x trailing earnings, MDT trades at a 19% valuation discount to LNTH's 26.7x P/E. Adjusting for growth (PEG ratio), RMD offers better value at 1.25x vs MDT's 36.00x — a lower PEG means you pay less per unit of expected earnings growth.

MetricLNTH logoLNTHLantheus Holdings…RMD logoRMDResMed Inc.MDT logoMDTMedtronic plcPHG logoPHGKoninklijke Phili…
Market CapShares × price$5.9B$30.1B$99.9B$25.8B
Enterprise ValueMkt cap + debt − cash$5.6B$29.8B$126.2B$32.1B
Trailing P/EPrice ÷ TTM EPS26.69x21.76x21.60x24.85x
Forward P/EPrice ÷ next-FY EPS est.17.52x18.78x14.13x17.55x
PEG RatioP/E ÷ EPS growth rate1.25x36.00x
EV / EBITDAEnterprise value multiple14.61x15.51x14.32x10.70x
Price / SalesMarket cap ÷ Revenue3.84x5.86x2.98x1.23x
Price / BookPrice ÷ Book value/share5.72x5.11x2.08x2.02x
Price / FCFMarket cap ÷ FCF16.73x18.14x19.28x24.62x
PHG leads this category, winning 3 of 7 comparable metrics.

Profitability & Efficiency

Evenly matched — LNTH and RMD each lead in 4 of 9 comparable metrics.

RMD delivers a 24.4% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $8 for PHG. LNTH carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to PHG's 0.74x. On the Piotroski fundamental quality scale (0–9), RMD scores 8/9 vs LNTH's 5/9, reflecting strong financial health.

MetricLNTH logoLNTHLantheus Holdings…RMD logoRMDResMed Inc.MDT logoMDTMedtronic plcPHG logoPHGKoninklijke Phili…
ROE (TTM)Return on equity+24.3%+24.4%+9.4%+8.2%
ROA (TTM)Return on assets+12.4%+18.0%+175.8%+3.4%
ROICReturn on invested capital+30.6%+22.8%+6.0%+6.4%
ROCEReturn on capital employed+17.1%+25.7%+7.5%+7.1%
Piotroski ScoreFundamental quality 0–95867
Debt / EquityFinancial leverage0.00x0.14x0.59x0.74x
Net DebtTotal debt minus cash-$358M-$358M$26.3B$5.3B
Cash & Equiv.Liquid assets$359M$1.2B$2.2B$2.8B
Total DebtShort + long-term debt$738,000$852M$28.5B$8.1B
Interest CoverageEBIT ÷ Interest expense11.72x66.06x9.08x4.34x
Evenly matched — LNTH and RMD each lead in 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — LNTH and PHG each lead in 3 of 6 comparable metrics.

A $10,000 investment in LNTH five years ago would be worth $41,420 today (with dividends reinvested), compared to $5,734 for PHG. Over the past 12 months, PHG leads with a +17.7% total return vs RMD's -14.5%. The 3-year compound annual growth rate (CAGR) favors PHG at 11.6% vs RMD's -2.9% — a key indicator of consistent wealth creation.

MetricLNTH logoLNTHLantheus Holdings…RMD logoRMDResMed Inc.MDT logoMDTMedtronic plcPHG logoPHGKoninklijke Phili…
YTD ReturnYear-to-date+35.3%-15.2%-18.1%+0.3%
1-Year ReturnPast 12 months+13.1%-14.5%-2.8%+17.7%
3-Year ReturnCumulative with dividends-4.0%-8.4%-4.2%+38.8%
5-Year ReturnCumulative with dividends+314.2%+11.0%-27.7%-42.7%
10-Year ReturnCumulative with dividends+4192.5%+293.8%+26.5%+48.3%
CAGR (3Y)Annualised 3-year return-1.4%-2.9%-1.4%+11.6%
Evenly matched — LNTH and PHG each lead in 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — LNTH and MDT each lead in 1 of 2 comparable metrics.

MDT is the less volatile stock with a 0.47 beta — it tends to amplify market swings less than PHG's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LNTH currently trades 97.8% from its 52-week high vs RMD's 70.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricLNTH logoLNTHLantheus Holdings…RMD logoRMDResMed Inc.MDT logoMDTMedtronic plcPHG logoPHGKoninklijke Phili…
Beta (5Y)Sensitivity to S&P 5000.47x0.66x0.47x1.12x
52-Week HighHighest price in past year$93.00$293.81$106.33$33.44
52-Week LowLowest price in past year$47.25$198.64$77.16$21.95
% of 52W HighCurrent price vs 52-week peak+97.8%+70.4%+73.3%+81.2%
RSI (14)Momentum oscillator 0–10061.235.627.347.7
Avg Volume (50D)Average daily shares traded886K1.1M7.8M1.0M
Evenly matched — LNTH and MDT each lead in 1 of 2 comparable metrics.

Analyst Outlook

MDT leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: LNTH as "Buy", RMD as "Buy", MDT as "Buy", PHG as "Hold". Consensus price targets imply 40.5% upside for MDT (target: $110) vs 11.0% for LNTH (target: $101). For income investors, MDT offers the higher dividend yield at 3.57% vs RMD's 1.02%.

MetricLNTH logoLNTHLantheus Holdings…RMD logoRMDResMed Inc.MDT logoMDTMedtronic plcPHG logoPHGKoninklijke Phili…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyHold
Price TargetConsensus 12-month target$101.00$281.29$109.50
# AnalystsCovering analysts17354922
Dividend YieldAnnual dividend ÷ price+1.0%+3.6%+1.5%
Dividend StreakConsecutive years of raises014361
Dividend / ShareAnnual DPS$2.11$2.78$0.34
Buyback YieldShare repurchases ÷ mkt cap+5.1%+1.0%+3.2%0.0%
MDT leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

RMD leads in 1 of 6 categories (Income & Cash Flow). PHG leads in 1 (Valuation Metrics). 3 tied.

Best OverallResMed Inc. (RMD)Leads 1 of 6 categories
Loading custom metrics...

LNTH vs RMD vs MDT vs PHG: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is LNTH or RMD or MDT or PHG a better buy right now?

For growth investors, ResMed Inc.

(RMD) is the stronger pick with 9. 8% revenue growth year-over-year, versus -1. 0% for Koninklijke Philips N. V. (PHG). Medtronic plc (MDT) offers the better valuation at 21. 6x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate Lantheus Holdings, Inc. (LNTH) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — LNTH or RMD or MDT or PHG?

On trailing P/E, Medtronic plc (MDT) is the cheapest at 21.

6x versus Lantheus Holdings, Inc. at 26. 7x. On forward P/E, Medtronic plc is actually cheaper at 14. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ResMed Inc. wins at 1. 08x versus Medtronic plc's 36. 00x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — LNTH or RMD or MDT or PHG?

Over the past 5 years, Lantheus Holdings, Inc.

(LNTH) delivered a total return of +314. 2%, compared to -42. 7% for Koninklijke Philips N. V. (PHG). Over 10 years, the gap is even starker: LNTH returned +41. 9% versus MDT's +26. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — LNTH or RMD or MDT or PHG?

By beta (market sensitivity over 5 years), Medtronic plc (MDT) is the lower-risk stock at 0.

47β versus Koninklijke Philips N. V. 's 1. 12β — meaning PHG is approximately 140% more volatile than MDT relative to the S&P 500. On balance sheet safety, Lantheus Holdings, Inc. (LNTH) carries a lower debt/equity ratio of 0% versus 74% for Koninklijke Philips N. V. — giving it more financial flexibility in a downturn.

05

Which is growing faster — LNTH or RMD or MDT or PHG?

By revenue growth (latest reported year), ResMed Inc.

(RMD) is pulling ahead at 9. 8% versus -1. 0% for Koninklijke Philips N. V. (PHG). On earnings-per-share growth, the picture is similar: Koninklijke Philips N. V. grew EPS 224. 0% year-over-year, compared to -21. 8% for Lantheus Holdings, Inc.. Over a 3-year CAGR, LNTH leads at 18. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — LNTH or RMD or MDT or PHG?

ResMed Inc.

(RMD) is the more profitable company, earning 27. 2% net margin versus 5. 0% for Koninklijke Philips N. V. — meaning it keeps 27. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RMD leads at 32. 7% versus 8. 0% for PHG. At the gross margin level — before operating expenses — MDT leads at 65. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is LNTH or RMD or MDT or PHG more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, ResMed Inc. (RMD) is the more undervalued stock at a PEG of 1. 08x versus Medtronic plc's 36. 00x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Medtronic plc (MDT) trades at 14. 1x forward P/E versus 18. 8x for ResMed Inc. — 4. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MDT: 40. 5% to $109. 50.

08

Which pays a better dividend — LNTH or RMD or MDT or PHG?

In this comparison, MDT (3.

6% yield), PHG (1. 5% yield), RMD (1. 0% yield) pay a dividend. LNTH does not pay a meaningful dividend and should not be held primarily for income.

09

Is LNTH or RMD or MDT or PHG better for a retirement portfolio?

For long-horizon retirement investors, ResMed Inc.

(RMD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 66), 1. 0% yield, +293. 8% 10Y return). Both have compounded well over 10 years (RMD: +293. 8%, PHG: +48. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between LNTH and RMD and MDT and PHG?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: LNTH is a small-cap quality compounder stock; RMD is a mid-cap quality compounder stock; MDT is a mid-cap income-oriented stock; PHG is a mid-cap quality compounder stock. RMD, MDT, PHG pay a dividend while LNTH does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

LNTH

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 10%
Run This Screen
Stocks Like

RMD

Quality Mega-Cap Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 16%
Run This Screen
Stocks Like

MDT

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 7%
Run This Screen
Stocks Like

PHG

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 5%
  • Dividend Yield > 0.5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform LNTH and RMD and MDT and PHG on the metrics below

Revenue Growth>
%
(LNTH: 1.2% · RMD: 10.8%)
Net Margin>
%
(LNTH: 18.0% · RMD: 27.4%)
P/E Ratio<
x
(LNTH: 26.7x · RMD: 21.8x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.